Matheis Dennis 4
4 · Lucid Diagnostics Inc. · Filed May 22, 2025
Insider Transaction Report
Form 4
Matheis Dennis
Director
Transactions
- Purchase
Common Stock
2025-05-21$1.32/sh+129,684$171,520→ 316,782 total - Purchase
Common Stock
2025-05-22$1.32/sh+33,218$43,795→ 350,000 total - Purchase
Common Stock
2025-05-20$1.29/sh+187,098$242,292→ 187,098 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.265 to $1.30. inclusive. The reporting person undertakes to provide to Lucid Diagnostics Inc., any security holder of Lucid Diagnostics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.315 to $1.32, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.305 to $1.32, inclusive.